These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9189179)

  • 21. Treatment for metastatic malignant melanoma: old drugs and new strategies.
    Mouawad R; Sebert M; Michels J; Bloch J; Spano JP; Khayat D
    Crit Rev Oncol Hematol; 2010 Apr; 74(1):27-39. PubMed ID: 19781957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemotherapy of malignant melanoma].
    Karakousis CP
    Chirurg; 1986 Oct; 57(10):606-11. PubMed ID: 3792110
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of interferon alfa as adjuvant therapy for advanced cutaneous melanoma: the need for more evidence.
    Kimyai-Asadi A; Usman A
    J Am Acad Dermatol; 2000 Oct; 43(4):708-11. PubMed ID: 11004636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interferons and malignant melanoma].
    Dreno B
    Rev Med Interne; 2002 Nov; 23 Suppl 4():489s-493s. PubMed ID: 12481404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy for metastatic melanoma.
    Mandarà M; Nortilli R; Sava T; Cetto GL
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):121-30. PubMed ID: 16375649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic treatment of metastatic melanoma with chemotherapy.
    Green RJ; Schuchter LM
    Hematol Oncol Clin North Am; 1998 Aug; 12(4):863-75, viii. PubMed ID: 9759584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dacarbazine, nimustine hydrochloride, cisplatin and tamoxifen combination chemotherapy for advanced malignant melanoma.
    Yamazaki N; Yamamoto A; Wada T; Ishikawa M
    J Dermatol; 1999 Aug; 26(8):489-93. PubMed ID: 10487002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of interferons in the therapy of melanoma.
    Castello G; Ruocco V; Satriano RA; Zarrilli D
    Melanoma Res; 1992; 1(5-6):311-25. PubMed ID: 1384854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined treatment with dacarbazine, cisplatin, fotemustine and tamoxifen in metastatic malignant melanoma.
    Richard MA; Grob JJ; Zarrour H; Bassères N; Bizzari JP; Gérard B; Bonerandi JJ
    Melanoma Res; 1998 Apr; 8(2):170-4. PubMed ID: 9610872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained complete remission after chemobiohormonal therapy for metastatic melanoma.
    Stein ME; Bernstein Z; Drumea K; Zalik M; Shklar Z; Steiner M; Haim N
    Am J Clin Oncol; 1999 Feb; 22(1):62-4. PubMed ID: 10025383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in the treatment of patients with advanced malignant melanoma.
    Feun LG; Savaraj N; Hurley J; Marini A; Lai S
    Cancer; 2000 Feb; 88(3):584-8. PubMed ID: 10649251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tamoxifen in the treatment of metastatic malignant melanoma: still a controversy? (Review).
    Toma S; Ugolini D; Palumbo R
    Int J Oncol; 1999 Aug; 15(2):321-37. PubMed ID: 10402244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How melanoma is treated in real life.
    Dummer R; Schadendorf D
    Arch Dermatol; 2008 May; 144(5):664-5. PubMed ID: 18490596
    [No Abstract]   [Full Text] [Related]  

  • 34. A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma.
    Middleton MR; Lorigan P; Owen J; Ashcroft L; Lee SM; Harper P; Thatcher N
    Br J Cancer; 2000 Mar; 82(6):1158-62. PubMed ID: 10735499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2, granulocyte colony-stimulating factor, and tamoxifen for patients with metastatic melanoma.
    O'Day SJ; Gammon G; Boasberg PD; Martin MA; Kristedja TS; Guo M; Stern S; Edwards S; Fournier P; Weisberg M; Cannon M; Fawzy NW; Johnson TD; Essner R; Foshag LJ; Morton DL
    J Clin Oncol; 1999 Sep; 17(9):2752-61. PubMed ID: 10561350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term remissions in metastatic malignant melanoma following chemotherapy and tamoxifen maintenance.
    Metzner B; Casper J; Hartung G; Rosien B; Hölzle E; Pelzer P; Köhne CH
    Onkologie; 2011; 34(4):208-9. PubMed ID: 21447982
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of tamoxifen in the treatment of malignant melanoma.
    Lens MB; Reiman T; Husain AF
    Cancer; 2003 Oct; 98(7):1355-61. PubMed ID: 14508820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
    Serrone L; Zeuli M; Sega FM; Cognetti F
    J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evidence for tamoxifen and chemotherapy as treatment for metastatic melanoma.
    Rusthoven JJ
    Eur J Cancer; 1998 Jul; 34 Suppl 3():S31-6. PubMed ID: 9849407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifen: a prospective randomized study.
    Cocconi G; Passalacqua R; Foladore S; Carlini P; Acito L; Maiello E; Marchi M; Gebbia V; Di Sarra S; Beretta M; Bacchi M
    Melanoma Res; 2003 Feb; 13(1):73-9. PubMed ID: 12569288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.